Renee Amelia Walden, ARNP | |
560 Quick Rd, Castle Rock, WA 98611-9324 | |
(360) 274-6150 | |
Not Available |
Full Name | Renee Amelia Walden |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 28 Years |
Location | 560 Quick Rd, Castle Rock, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245294602 | NPI | - | NPPES |
9644634 | Medicaid | WA | |
6687WA | Other | WA | REGENCE BLUE SHIELD |
830346687-98611-A001 | Other | WA | TRICARE |
8940830 | Other | WA | CRIME VICTIMS OF WA |
194936 | Other | WA | LABOR & INDUSTRIES |
210235 | Medicaid | OR |
Facility Name | Location | Facility Type |
---|---|---|
Peacehealth St John Medical Center | Longview, WA | Hospital |
Mailing Address | Practice Location Address |
---|---|
Renee Amelia Walden, ARNP 560 Quick Rd, Castle Rock, WA 98611-9324 Ph: (360) 274-6150 | Renee Amelia Walden, ARNP 560 Quick Rd, Castle Rock, WA 98611-9324 Ph: (360) 274-6150 |
News Archive
From today, women in Scotland with an advanced and incurable form of cervical cancer could benefit from the targeted treatment Avastin, which has been given the green light by the Scottish Medicines Consortium (SMC) for routine use on the NHS.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that in two parallel Phase 3 studies in patients with the neovascular form of age-related macular degeneration (wet AMD), all regimens of VEGF Trap-Eye (aflibercept ophthalmic solution), including VEGF Trap-Eye dosed every two months, successfully met the primary endpoint compared to the current standard of care, ranibizumab dosed every month.
By using a new analysis method, researchers at Karolinska Institutet and Science for Life Laboratory (SciLifeLab) in Sweden have found close to one hundred novel human gene regions that code for proteins. A number of these regions are so-called pseudogenes, which may be linked to cancer.
KCI applauds the FDA for launching this important initiative to ensure that complex medical devices are used safely in the home by caregivers and patients. We have made it our priority and unwavering responsibility to help caregivers and patients understand how to use our advanced treatments safely. This includes offering a robust education and training program, employing highly trained clinical support staff and providing easy-to-read, patient-specific labeling.
› Verified 3 days ago